Status:
COMPLETED
Resveratrol as a Preventive Treatment of OHSS
Lead Sponsor:
IVI Madrid
Conditions:
Infertility
Eligibility:
FEMALE
18-35 years
Phase:
PHASE3
Brief Summary
Evaluation of resveratrol treatment oh ovarian hyperstimulation syndrome in egg donors
Detailed Description
Randomized clinical trial to evaluate the role of resveratrol in preventing ovarian hyperstimulation syndrome by reducing VGEF expression and estradiol production, imporving hemoconcentration and symp...
Eligibility Criteria
Inclusion
- Number of follicles greater than 12 mm after ovarian stimulation
- Number of retrieved oocytes greater than 21
Exclusion
- \>35 years-old
- PCOS
- Endometriosis
- Systemic pathology
- Positive serologies for HBV, HBC and HIV
- Abnormal karyotype
Key Trial Info
Start Date :
March 13 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2019
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT03446625
Start Date
March 13 2018
End Date
June 1 2019
Last Update
August 20 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ivi Madrid
Madrid, Spain, 28023